News and Announcements
Proteomics International’s PromarkerD Test Latest Comprehensive Update
- Published April 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Proteomics International Laboratories Ltd (ASX: PIQ) (PILL), the leader in predictive diagnostics for diabetic kidney disease, presents a comprehensive update on the commercialisation progress for its PromarkerD test.
KEY TAKEAWAYS:
- PromarkerD rated the world’s leading diagnostic test for diabetic kidney disease by global market research firm Frost & Sullivan;
- First licensing income received;
- Key patents secured and extended;
- Clinical laboratory prototype manufacture on target for mid-2017;
- First commercial sales are targeted for the end of 2017;
- Validation study completed – announcement of results pending publication of the prior predictive development study;
- Development study shows PromarkerD correctly predicts 95% of otherwise healthy diabetics who will develop chronic kidney disease;
- Discussions continue with prospective diagnostic companies in the USA, China, Europe, Australia and Japan to secure licences for the commercialisation of PromarkerD.
PromarkerD is a predictive diagnostic test for diabetic kidney disease. In a clinical study PromarkerD correctly predicted 95% of otherwise healthy diabetics who went on to develop chronic kidney disease within four years. PromarkerD was last month rated the world’s leading diagnostic test for diabetic kidney disease in the Frost & Sullivan report Biomarkers Enabling Diabetes and Obesity Management.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
